The angiotensin type 2 receptor agonist C21 restores respiratory function in COVID19 - a double-blind, randomized, placebo-controlled Phase 2 trial
bioRxiv (2021) - Comments
doi: 10.1101/2021.01.26.21250511 

Göran Tornling, Rohit Batta, Joanna Porter, Thomas Bengtsson, Kartikeya Parmar, Reema Kashiva, Anders Hallberg, Anne Katrine Cohrt, Kate Westergaard, Carl-Johan Dalsgaard, Johan Raud